PIONORM

This brand name is authorized in Nigeria.

Active ingredients

The drug PIONORM contains one active pharmaceutical ingredient (API):

1	Pioglitazone UNII JQT35NPK6C - PIOGLITAZONE HYDROCHLORIDE
	Pioglitazone effects may be mediated by a reduction of insulin resistance. Pioglitazone appears to act via activation of specific nuclear receptors (peroxisome proliferator activated receptor gamma) leading to increased insulin sensitivity of liver, fat and skeletal muscle cells in animals. Treatment with pioglitazone has been shown to reduce hepatic glucose output and to increase peripheral glucose disposal in the case of insulin resistance.
	Read more about Pioglitazone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4583	Tablet	Pionorm 30 Tablets TAB 30 mg 3x10	Pionorm 30 Tablets PIOGLITAZONE HYDROCHLORIDE TABLETS 30MG Pioglitazone Hydrochloride Tablets 30mg. 1 Lactose Monohydrate 2 Croscarmellose Sodium (Primellose) 3 Hydroxy propyl cellulose (KLUCEL-LF) 4 Magnesium Stearate 5 Purified water. A4-4583 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 16/12/2021 MICRO NOVA PHARMACEUTICALS IND. LTD, PLOT 3, BILLINGS WAY, INDUSTRIAL ESTATE, IKEJA IKEJA LAGOS 81299901 solomonsemicrolabs@gmail.com M/S MICRO LABS LIMITED., 92, SIPCOT IND. COMPLEX HOSUR 635126 INDIA, India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BG03	Pioglitazone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4583